On Demand CE: Pharmacology Course 2017: The Co-Morbid CVD Patient

Pharmacology Course 2017: The Co-Morbid CVD Patient

Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. PCNA has developed an annual pharmacology CE program to meet the clinical practice and recertification needs of these clinicians.

This year, course director Cindy Lamendola, MSN, NP, and faculty Carol Headley, DNSc., ACNP, RN, CNN and Wei Jiang, MD have developed a curriculum that includes a comprehensive approach to Pharmacology in:
  1. Cardio-Metabolic Risk Reduction in patients with pre-diabetes and DM2 
  2. It’s a Balancing Act: Medication Management in Patients with CKD and CVD and 
  3. Pharmacological Management of the Cardiac Patient with Depression and/or Anxiety
Those who satisfactorily complete this course will earn 7.0 contact hours in the area of pharmacology. Independent self-paced pre and post course evaluation are included. 

Credit: 7.00 Hour Pharmacology CE 
Cost: $45 for members, $115 for non-members

Take this Course


  • Cindy Lamendola MSN, NP, FAHA, FPCNA
  • Carol Headley DNSc., ACNP, RN, CNN
  • Wei Jiang, MD

Upon completion of this program, participants will be able to: 

    • Understand the relationship of the patient with cardio metabolic risks and CVD
    • Describe assessment for CVD and DM risk in these patient populations.
    • Understand the role of glucose lowering medications and CVD
    • Describe the treatment for CVD risk reduction in these patient populations
    • Summarize the evidence linking CVD events and mortality in patients with CKD
    • Outline the assessment of a patient with CKD and CVD including common lab tests and biomarkers
    • Review best practices in medication dosing, safety and tolerance in patients with CKD and CVD
    • Provide an overview of pharmacotherapies used to prevent the progression of renal dysfunction and reduce CVD risk in patients with CKD
    • Describe the relationship between depression, anxiety and CVD
    • Provide overview of clinical screening tools for depression and anxiety
    • Describe how to select and titrate anti-depression and anti-anxiety therapies
    • Review potential interactions between antidepressant/antianxiety therapies and cardiovascular medications

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602.